2009-01-01

Medigen Biotechnology Corporation now ASHI laboratory accredited for HLA typing (NEW)

ASHI accreditation a first for Taiwan based HLA typing laboratory 
Medigen Biotechnology Corporation, the parent company of Texas Biogene Inc., has received laboratory accreditation by the American Society of Histocompatibility and Immunogenetics (ASHI) for the time period from 01/01/2009 to 12/31/2010.  With over 200 ASHI accredited laboratories worldwide, Medigen is the only ASHI accredited laboratory with both low and high resolution HLA typing service in Taiwan.  Our aim is to promote quality practice in Histocompatibility and Immunogenetics through compliance with ASHI standards and to integrate the valuable resources in organ transplantation and blood banking in Taiwan into the international arena.  The accreditation process included a rigorous evaluation of laboratory personnel, procedures and facilities to determine if they are in compliance with published standards of ASHI.  Under the guidance of an accredited US based laboratory director Medigen is now offering exceptional low and high resolution HLA typing service by maintaining the highest standards of reliability and quality in histocompatibility testing laboratories.